Sherrill & Hutchins Financial Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,161
Closed -$447K 16
2025
Q4
$447K Hold
2,161
0.32% 11
2025
Q3
$401K Hold
2,161
0.29% 11
2025
Q2
$330K Sell
2,161
-2
-0.1% -$307 0.26% 11
2025
Q1
$359K Buy
2,163
+2
+0.1% +$313 0.31% 11
2024
Q4
$313K Hold
2,161
0.28% 10
2024
Q3
$350K Hold
2,161
0.3% 10
2024
Q2
$316K Hold
2,161
0.29% 10
2024
Q1
$342K Hold
2,161
0.31% 8
2023
Q4
$339K Buy
+2,161
New +$331K 0.32% 10

Other funds holding JNJ

Sherrill & Hutchins Financial Advisory's JNJ Position: Q1 2026 in Review

Sherrill & Hutchins Financial Advisory sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 2,161 shares — an estimated $447K sold.

Sherrill & Hutchins Financial Advisory first reported a position in JNJ in Q4 2023 and held it in 9 quarters. The position peaked at $447K in Q4 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sherrill & Hutchins Financial Advisory reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Sherrill & Hutchins Financial Advisory sold 2,161 Johnson & Johnson shares in Q1 2026, an estimated $447K.
  • Sherrill & Hutchins Financial Advisory first reported a position in Johnson & Johnson in Q4 2023 and held it in 9 quarters.
  • Sherrill & Hutchins Financial Advisory's Johnson & Johnson position peaked at $447K in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sherrill & Hutchins Financial Advisory's 13F filing for Q1 2026, filed 22 Apr 2026.